An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers Publisher Pubmed

Farzaneh M¹ ; Masoodi T² ; Ghaedrahmati F³ ; Radoszkiewicz K⁴ ; Anbiyaiee A⁵ ; Sheykhisabzehpoush M⁶ ; Rad NK⁷ ; Uddin S⁸ ; Jooybari SPM⁹ ; Khoshnam SE^{10, 11} ; Azizidoost S¹²

Source: Pathology Research and Practice Published:2023

Abstract

Long non-coding RNAs (lncRNAs) present pivotal roles in cancer tumorigenesis and progression. Recently, nuclear paraspeckle assembly transcript 1 (NEAT1) as a lncRNA has been shown to mediate cell proliferation, migration, and EMT in tumor cells. NEAT1 by targeting several miRNAs/mRNA axes could regulate cancer cell behavior. Therefore, NEAT1 may function as a potent biomarker for the prediction and treatment of some human cancers. In this review, we summarized various NEAT1-related signaling pathways that are critical in cancer initiation and progression. © 2023

Related Docs

View other Related Docs

1. Emerging Roles for Lncrna-Neat1 in Colorectal Cancer, Cancer Cell International (2022)

2. Exploring Potential Roles of Long Non-Coding Rnas in Cancer Immunotherapy: A Comprehensive Review, Frontiers in Immunology (2024)

3. Long Non-Coding Rnas and Melanoma: From Diagnosis to Therapy, Pathology Research and Practice (2023)

Experts (# of related papers)

View all Related Experts

Mohammadreza Sharifi (2)

Mohammad Kazemi (1)

Other Related Docs

4. The Pathogenic Roles of Lncrna-Taurine Upregulated 1 (Tug1) in Colorectal Cancer, Cancer Cell International (2022)

5. Potential Roles of Lncrna-Xist/Mirnas/Mrnas in Human Cancer Cells, Clinical and Translational Oncology (2023)

6. A Comprehensive Review of the Role of Lncrnas in Gastric Cancer (Gc) Pathogenesis, Immune Regulation, and Their Clinical Applications, Pathology Research and Practice (2023)

7. Non-Coding Rnas and Glioblastoma: Insight Into Their Roles in Metastasis, Molecular Therapy Oncolytics (2022)

8. Multiple Function of Lncrna Malat1 in Cancer Occurrence and Progression, Chemical Biology and Drug Design (2023)

9. Exploring the Dual Role of Malat1 in Thyroid Tumorigenesis: Oncogenic or Tumor Suppressor?, Current Molecular Medicine (2025)

10. Dysregulated Expression and Functions of Microrna-330 in Cancers: A Potential Therapeutic Target, Biomedicine and Pharmacotherapy (2022)

11. Systems Biology Unravels the Relationship of Lncrna Oip5-As1 With Cd25, Gene Reports (2021)

12. Construction of a Cell Cycle-Specific Lncrna-Mirna-Mrna Network Reveals Novel Key Lncrnas in Colorectal Cancer, Biomarkers (2024)

13. Induction of Apoptosis and Necrosis in Human Acute Erythroleukemia Cells by Inhibition of 47Tlong Non-Coding Rna Pvt1, Molecular Biology Research Communications (2018)

14. Signaling Pathways Governing Glioma Cancer Stem Cells Behavior, Cellular Signalling (2023)

15. Cross-Talk Between Oxidative Stress Signaling and Microrna Regulatory Systems in Carcinogenesis: Focused on Gastrointestinal Cancers, Biomedicine and Pharmacotherapy (2020)

16. Competing Endogenous Rnas Regulatory Crosstalk Networks: The Messages From the Rna World to Signaling Pathways Directing Cancer Stem Cell Development, Heliyon (2024)

17. Inhibition of Microrna Mir-92A Induces Apoptosis and Inhibits Cell Proliferation in Human Acute Promyelocytic Leukemia Through Modulation of P63 Expression, Molecular Biology Reports (2014)

18. Mir-1236: Key Controller of Tumor Development and Progression: Focus on the Biological Functions and Molecular Mechanisms, Pathology Research and Practice (2023)

19. A Pan-Cancer Analysis Indicates Long Noncoding Rna Hand2-As1 As a Potential Prognostic, Immunomodulatory and Therapeutic Biomarker in Various Cancers Including Colorectal Adenocarcinoma, Cancer Cell International (2023)

20. Long Noncoding Rna-Mirna-Mrna Axes Multiple Roles in Osteosarcoma, Gene Reports (2021)

Style	Citing Format
MLA	Farzaneh M, et al.. "An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers." Pathology Research and Practice, vol. 245, no. , 2023, pp. -.
APA	Farzaneh M, Masoodi T, Ghaedrahmati F, Radoszkiewicz K, Anbiyaiee A, Sheykhisabzehpoush M, Rad NK, Uddin S, Jooybari SPM, Khoshnam SE, Azizidoost S (2023). An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers. Pathology Research and Practice, 245(), -.
Chicago	Farzaneh M, Masoodi T, Ghaedrahmati F, Radoszkiewicz K, Anbiyaiee A, Sheykhisabzehpoush M, Rad NK, et al.. "An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers." Pathology Research and Practice 245, no. (2023): -.
Harvard	Farzaneh M et al. (2023) 'An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers', Pathology Research and Practice, 245(), pp. -.
Vancouver	Farzaneh M, Masoodi T, Ghaedrahmati F, Radoszkiewicz K, Anbiyaiee A, Sheykhisabzehpoush M, et al.. An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers. Pathology Research and Practice. 2023;245():-.
BibTex	@article{ author = {Farzaneh M and Masoodi T and Ghaedrahmati F and Radoszkiewicz K and Anbiyaiee A and Sheykhisabzehpoush M and Rad NK and Uddin S and Jooybari SPM and Khoshnam SE and Azizidoost S}, title = {An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers}, journal = {Pathology Research and Practice}, volume = {245}, number = {}, pages = {-}, year = {2023} }
RIS	TY - JOUR AU - Farzaneh M AU - Masoodi T AU - Ghaedrahmati F AU - Radoszkiewicz K AU - Anbiyaiee A AU - Sheykhisabzehpoush M AU - Rad NK AU - Uddin S AU - Jooybari SPM AU - Khoshnam SE AU - Azizidoost S TI - An Updated Review of Contribution of Long Noncoding Rna-Neat1 to the Progression of Human Cancers JO - Pathology Research and Practice VL - 245 IS - SP - EP - PY - 2023 ER -

Science Communicator Platform

Authors

Abstract